221 related articles for article (PubMed ID: 30837304)
1. Excitatory neuron-specific SHP2-ERK signaling network regulates synaptic plasticity and memory.
Ryu HH; Kim T; Kim JW; Kang M; Park P; Kim YG; Kim H; Ha J; Choi JE; Lee J; Lim CS; Kim CH; Kim SJ; Silva AJ; Kaang BK; Lee YS
Sci Signal; 2019 Mar; 12(571):. PubMed ID: 30837304
[TBL] [Abstract][Full Text] [Related]
2. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.
De Rocca Serra-Nédélec A; Edouard T; Tréguer K; Tajan M; Araki T; Dance M; Mus M; Montagner A; Tauber M; Salles JP; Valet P; Neel BG; Raynal P; Yart A
Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4257-62. PubMed ID: 22371576
[TBL] [Abstract][Full Text] [Related]
3. Noonan syndrome-associated SHP2 mutation differentially modulates the expression of postsynaptic receptors according to developmental maturation.
Oh JY; Rhee S; Silva AJ; Lee YS; Kim HK
Neurosci Lett; 2017 May; 649():41-47. PubMed ID: 28366775
[TBL] [Abstract][Full Text] [Related]
4. Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase.
Miura K; Wakayama Y; Tanino M; Orba Y; Sawa H; Hatakeyama M; Tanaka S; Sabe H; Mochizuki N
Oncogene; 2013 Nov; 32(45):5292-301. PubMed ID: 23318428
[TBL] [Abstract][Full Text] [Related]
5. Increased Activity of Src Homology 2 Domain Containing Phosphotyrosine Phosphatase 2 (Shp2) Regulates Activity-dependent AMPA Receptor Trafficking.
Zhang B; Du YL; Lu W; Yan XY; Yang Q; Yang W; Luo JH
J Biol Chem; 2016 Sep; 291(36):18856-66. PubMed ID: 27417137
[TBL] [Abstract][Full Text] [Related]
6. Shp2 in forebrain neurons regulates synaptic plasticity, locomotion, and memory formation in mice.
Kusakari S; Saitow F; Ago Y; Shibasaki K; Sato-Hashimoto M; Matsuzaki Y; Kotani T; Murata Y; Hirai H; Matsuda T; Suzuki H; Matozaki T; Ohnishi H
Mol Cell Biol; 2015 May; 35(9):1557-72. PubMed ID: 25713104
[TBL] [Abstract][Full Text] [Related]
7. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
8. Exploring the effect of D61G mutation on SHP2 cause gain of function activity by a molecular dynamics study.
Li HL; Ma Y; Zheng CJ; Jin WY; Liu WS; Wang RL
J Biomol Struct Dyn; 2018 Nov; 36(14):3856-3868. PubMed ID: 29125030
[TBL] [Abstract][Full Text] [Related]
9. A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma.
Hu Z; Wang X; Fang H; Liu Y; Chen D; Zhang Q; Liu X; Wei D; Qu C; Wang S
Oncotarget; 2016 Feb; 7(5):5664-76. PubMed ID: 26673822
[TBL] [Abstract][Full Text] [Related]
10. Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras/extracellular signal-regulated kinase (ERK) pathway.
Quintanar-Audelo M; Yusoff P; Sinniah S; Chandramouli S; Guy GR
J Biol Chem; 2011 Jul; 286(26):23102-12. PubMed ID: 21531714
[TBL] [Abstract][Full Text] [Related]
11. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; Fei F; Firestone B; Fodor M; Fridrich C; Gao H; Grunenfelder D; Hao HX; Jacob J; Ho S; Hsiao K; Kang ZB; Karki R; Kato M; Larrow J; La Bonte LR; Lenoir F; Liu G; Liu S; Majumdar D; Meyer MJ; Palermo M; Perez L; Pu M; Price E; Quinn C; Shakya S; Shultz MD; Slisz J; Venkatesan K; Wang P; Warmuth M; Williams S; Yang G; Yuan J; Zhang JH; Zhu P; Ramsey T; Keen NJ; Sellers WR; Stams T; Fortin PD
Nature; 2016 Jul; 535(7610):148-52. PubMed ID: 27362227
[TBL] [Abstract][Full Text] [Related]
12. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.
McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW
J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542
[TBL] [Abstract][Full Text] [Related]
13. Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome.
Lee YS; Ehninger D; Zhou M; Oh JY; Kang M; Kwak C; Ryu HH; Butz D; Araki T; Cai Y; Balaji J; Sano Y; Nam CI; Kim HK; Kaang BK; Burger C; Neel BG; Silva AJ
Nat Neurosci; 2014 Dec; 17(12):1736-43. PubMed ID: 25383899
[TBL] [Abstract][Full Text] [Related]
14. Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development.
Deng R; Zhao X; Qu Y; Chen C; Zhu C; Zhang H; Yuan H; Jin H; Liu X; Wang Y; Chen Q; Huang J; Yu J
Oncotarget; 2015 Apr; 6(11):9355-69. PubMed ID: 25823821
[TBL] [Abstract][Full Text] [Related]
15. Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor.
Meng S; Chen Z; Munoz-Antonia T; Wu J
Biochem J; 2005 Oct; 391(Pt 1):143-51. PubMed ID: 15952937
[TBL] [Abstract][Full Text] [Related]
16. The Noonan syndrome-associated D61G variant of the protein tyrosine phosphatase SHP2 prevents synaptic down-scaling.
Lu W; Ai H; Xue F; Luan Y; Zhang B
J Biol Chem; 2020 Jul; 295(29):10023-10031. PubMed ID: 32499374
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner.
Zheng H; Yu WM; Waclaw RR; Kontaridis MI; Neel BG; Qu CK
Sci Signal; 2018 Mar; 11(522):. PubMed ID: 29559584
[TBL] [Abstract][Full Text] [Related]
18. Loss of Shp2-mediated mitogen-activated protein kinase signaling in Muller glial cells results in retinal degeneration.
Cai Z; Simons DL; Fu XY; Feng GS; Wu SM; Zhang X
Mol Cell Biol; 2011 Jul; 31(14):2973-83. PubMed ID: 21576358
[TBL] [Abstract][Full Text] [Related]
19. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
[TBL] [Abstract][Full Text] [Related]
20. Increased Src Family Kinase Activity Disrupts Excitatory Synaptic Transmission and Impairs Remote Fear Memory in Forebrain Shp2-Deficient Mice.
Yan X; Zhang B; Lu W; Peng L; Yang Q; Cao W; Lin S; Yu W; Li X; Ke Y; Li S; Yang W; Luo J
Mol Neurobiol; 2017 Nov; 54(9):7235-7250. PubMed ID: 27796759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
